Myasthenia Gravis :: New treatment boosts muscle function in myasthenia gravis

A new type of treatment significantly reduces the severity of muscle weakness in myasthenia gravis (MG), giving hope for a new class of drugs to treat neurological disorders, according to a study published in the August 14, 2007, issue of Neurology?, the medical journal of the American Academy of Neurology.

Myositis :: NIH gives $8M to University of Pittsburgh School of Medicine for myositis research

Researchers from the division of rheumatology and clinical immunology at the University of Pittsburgh School of Medicine are leading a worldwide effort to study a treatment for a rare autoimmune disorder called myositis, thanks to a five-year, $8 million contract from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health (NIH).

Stroke :: Promote stroke awareness in Hispanic Community

The National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), announced the launch of a new community education program, which broadens the Institute?s national stroke education campaign Know Stroke. Know the Signs. Act in Time. to promote stroke awareness among Hispanics in the United States.